TNF‐α blockers for Kawasaki disease in children
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"TNF‐α Blockers for Kawasaki Disease in Children." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305309/all/_________TNF‐α_blockers_for_Kawasaki_disease_in_children______.
TNF‐α blockers for Kawasaki disease in children. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305309/all/_________TNF‐α_blockers_for_Kawasaki_disease_in_children______. Accessed August 31, 2024.
TNF‐α blockers for Kawasaki disease in children. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305309/all/_________TNF‐α_blockers_for_Kawasaki_disease_in_children______
TNF‐α Blockers for Kawasaki Disease in Children [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 August 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305309/all/_________TNF‐α_blockers_for_Kawasaki_disease_in_children______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - TNF‐α blockers for Kawasaki disease in children
ID - 1305309
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305309/all/_________TNF‐α_blockers_for_Kawasaki_disease_in_children______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -